Entrada Therapeutics Inc
TRDA
$6.71+1.05%
End of day · as of Sep 23, 2026, 7:15 AM ET
Mkt cap
$274.40M
EV/Sales
7.24
P/E ratio
N/A
FY2025 Revenue
$25.42M
EPS (TTM)
$-3.96
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-565.48%
Beta
-0.06
Div yield
N/A
Sector
Healthcare
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported TRDA revenue for 2025-12-31 was $25.4M. Net income was -$143.8M. Revenue was down 87.9% from 2024-12-31 to 2025-12-31. TRDA currently screens at market cap $274.4M.
Use this TRDA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TRDA income, balance, and cash tables.
Entrada Therapeutics Inc (TRDA) is a biotechnology company in the Healthcare sector.
Latest cached Entrada Therapeutics Inc (TRDA) revenue for Dec 31, 2025 was $25.4M. Net income was -$143.8M. Statements: https://lician.com/financials/trda
Entrada Therapeutics Inc (TRDA) market capitalization is $274.4M on the latest cached snapshot.
Entrada Therapeutics Inc (TRDA) cached previous close $6.64; day range $6.65 – $6.93; volume 193,342. Session quote: https://lician.com/quote/trda
Entrada Therapeutics Inc (TRDA) latest cached earnings event is "TRDA earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TRDA filing is 8-K · Oct 14, 2026. Filings: https://lician.com/sec/trda